Based on the CorMedix Inc stock forecast from 6 analysts, the average analyst target price for CorMedix Inc is USD 16.18 over the next 12 months. CorMedix Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of CorMedix Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, CorMedix Inc’s stock price was USD 6.91. CorMedix Inc’s stock price has changed by +17.92% over the past week, -34.75% over the past month and +18.32% over the last year.
Past 12 monthsNext 12 months
No recent analyst target price found for CorMedix Inc
No recent average analyst rating found for CorMedix Inc
Company Overview CorMedix Inc
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Read Less
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock soluti...Read More
Frequently Asked Questions About CorMedix Inc (CRMD) Stock
Based on ratings from 6 analysts CorMedix Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and hold ratings.
Unfortunately we do not have enough data on CRMD's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for CRMD is USD 16.18 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 12.
Unfortunately we do not have enough data on CRMD's stock to indicate if its overvalued.
The last closing price of CRMD's stock was USD 6.91.
The most recent market capitalization for CRMD is USD 0.65B.
Based on targets from 6 analysts, the average taret price for CRMD is projected at USD 16.18 over the next 12 months.
This means that CRMD's stock price may go up by +134.18% over the next 12 months.
We can't find any ETFs which contains CorMedix Inc's stock.
As per our most recent records CorMedix Inc has 82 Employees.
CorMedix Inc's registered address is 300 Connell Drive, Berkeley Heights, NJ, United States, 07922.
You can get more information about it from CorMedix Inc's website at https://www.cormedix.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About CorMedix Inc (CRMD) Stock
Based on ratings from 6 analysts CorMedix Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and hold ratings.
Unfortunately we do not have enough data on CRMD's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for CRMD is USD 16.18 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 12.
Unfortunately we do not have enough data on CRMD's stock to indicate if its overvalued.
The last closing price of CRMD's stock was USD 6.91.
The most recent market capitalization for CRMD is USD 0.65B.
Based on targets from 6 analysts, the average taret price for CRMD is projected at USD 16.18 over the next 12 months.
This means that CRMD's stock price may go up by +134.18% over the next 12 months.
We can't find any ETFs which contains CorMedix Inc's stock.
As per our most recent records CorMedix Inc has 82 Employees.
CorMedix Inc's registered address is 300 Connell Drive, Berkeley Heights, NJ, United States, 07922.
You can get more information about it from CorMedix Inc's website at https://www.cormedix.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CRMD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
